A Massachusetts federal court denied Medtronic’s renewed bid for summary judgment against Anti-Kickback Statute (AKS)–based False Claims Act (FCA) claims. Applying the First Circuit’s recent decision ...
Medtronic officials today said the planned separation of its Diabetes business (MiniMed) remains on track, with future offerings also on the horizon. On the company’s second-quarter earnings call, CFO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback